Sinopharm Group Co (HK:1099) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sinopharm Group Co. reported a slight revenue increase of 2.65% for the quarter ending September 2024, but experienced a significant drop in operating profit by 25.05% compared to the same period last year. Despite a 9.27% increase in total assets, the net profit attributable to shareholders decreased by 10.39%, reflecting challenges in the company’s profitability.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.
